Document is current
Any future updates will be listed below
-
Authors
Seyringer, Simone https://orcid.org/0000-0003-0689-9160
Pilz, Micha J. https://orcid.org/0000-0003-4092-8797
Bottomley, Andrew https://orcid.org/0000-0002-3067-5207
King, Madeleine T. https://orcid.org/0000-0002-9734-1973
Norman, Richard https://orcid.org/0000-0002-3112-3893
Gamper, Eva M. https://orcid.org/0000-0002-1700-4054
,
-
Funding
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer (12/2016)
University of Innsbruck and Medical University of Innsbruck
- License Information
-
More Information
Article History
Received: 14 February 2024
Accepted: 25 September 2024
First Online: 20 November 2024
Declarations
:
: The authors have no conflict of interest to declare. The EORTC Quality of Life Group business model involves charges for commercial companies using EORTC instruments. Academic use of EORTC instruments is free of charge.
: All patients provided written informed consent when participating in the original trials which this retrospective analysis relies on. The original study protocols were developed in accordance with the Declaration of Helsinki and ethical approval was sought at participating centres. The data sharing agreement complies with GDPR 2016.
: All authors have approved the submission of the manuscript.
